Akari Therapeutics, Plc total revenue, net income and dynamics of changes in US dollar today
The dynamics of net revenue of Akari Therapeutics, Plc rose. The change amounted to 0 $. The dynamics of net revenue is shown in comparison with the previous report. Net income Akari Therapeutics, Plc - -5 838 501 $. Information about net income is used from open sources. The dynamics of Akari Therapeutics, Plc net income grew by 983 359 $ for the last reporting period. Schedule of the financial report of Akari Therapeutics, Plc for today. Information on Akari Therapeutics, Plc net income on the chart on this page is drawn in blue bars. The value of all Akari Therapeutics, Plc assets on the graph is shown in green.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
0 $
-
-5 838 501 $
-
31/12/2020
0 $
-
-6 821 860 $
-
30/09/2020
0 $
-
1 441 960 $
-
30/06/2020
0 $
-
-8 316 655 $
-
30/09/2019
0 $
-
-2 565 353 $
-
30/06/2019
0 $
-
-4 117 084 $
-
31/03/2019
0 $
-
-2 545 283 $
-
31/12/2018
0 $
-
-3 512 754 $
-
30/09/2018
0 $
-
-3 593 255 $
-
30/06/2018
0 $
-
-8 022 196 $
-
31/03/2018
0 $
-
-1 338 575 $
-
31/12/2017
0 $
-
-9 293 155 $
-
30/09/2017
0 $
-
-10 376 575 $
-
30/06/2017
0 $
-
-320 016 $
-
31/03/2017
0 $
-
-12 584 512 $
-
Show:
to
Akari Therapeutics, Plc financial report charts
Dates of Akari Therapeutics, Plc finance reports: 31/03/2017, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The latest date of the financial report of Akari Therapeutics, Plc is 31/03/2021. Operating income Akari Therapeutics, Plc is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Akari Therapeutics, Plc is -5 548 670 $
Akari Therapeutics, Plc quarterly report dates
Net income Akari Therapeutics, Plc is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Akari Therapeutics, Plc is -5 838 501 $ Current assets Akari Therapeutics, Plc is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Akari Therapeutics, Plc is 7 813 285 $ Total assets Akari Therapeutics, Plc refers to the total amount of assets owned by a person or entity. Total assets Akari Therapeutics, Plc is 7 839 745 $
Current cash Akari Therapeutics, Plc - the sum of all of the cash a company has on the date of report. Current cash Akari Therapeutics, Plc is 6 668 325 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
31/03/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-5 548 670 $
-6 895 508 $
-246 883 $
-5 011 609 $
-3 117 320 $
-6 031 447 $
11 962 $
-4 721 325 $
-5 685 943 $
-7 978 905 $
-4 307 769 $
-10 785 666 $
-8 541 198 $
-7 349 137 $
-8 283 189 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-5 838 501 $
-6 821 860 $
1 441 960 $
-8 316 655 $
-2 565 353 $
-4 117 084 $
-2 545 283 $
-3 512 754 $
-3 593 255 $
-8 022 196 $
-1 338 575 $
-9 293 155 $
-10 376 575 $
-320 016 $
-12 584 512 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
3 529 384 $
4 660 138 $
-1 592 531 $
3 020 432 $
1 763 057 $
3 593 341 $
-2 318 360 $
2 362 358 $
3 303 790 $
5 120 840 $
1 008 388 $
7 117 853 $
6 382 542 $
3 782 185 $
6 002 700 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
5 548 670 $
6 895 508 $
246 883 $
5 011 609 $
3 117 320 $
6 031 447 $
-11 962 $
4 721 325 $
5 685 943 $
7 978 905 $
4 307 769 $
10 785 666 $
8 541 198 $
7 349 137 $
8 283 189 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
7 813 285 $
14 577 657 $
13 667 042 $
14 425 691 $
10 632 223 $
5 090 536 $
8 613 145 $
7 454 322 $
12 040 817 $
16 523 273 $
25 266 305 $
28 813 086 $
22 194 398 $
31 805 099 $
36 281 918 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
7 839 745 $
14 604 807 $
13 693 716 $
14 452 180 $
10 669 758 $
5 151 021 $
8 809 770 $
8 029 554 $
12 627 231 $
17 119 546 $
25 495 541 $
29 050 343 $
22 427 457 $
32 053 341 $
36 516 909 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
6 668 325 $
14 055 777 $
12 317 798 $
12 746 266 $
6 268 667 $
2 736 663 $
6 145 555 $
5 446 138 $
10 073 345 $
15 069 942 $
-
-
20 973 940 $
30 118 882 $
24 919 058 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
7 419 301 $
6 523 436 $
7 589 606 $
4 918 267 $
6 149 188 $
8 279 592 $
-
-
-
-
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
23 781 441 $
28 106 671 $
20 973 940 $
30 118 882 $
34 941 021 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
7 419 301 $
6 523 436 $
7 589 606 $
4 918 267 $
6 324 243 $
8 492 796 $
-
-
-
-
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
69.54 %
126.64 %
86.15 %
61.25 %
50.08 %
49.61 %
-
-
-
-
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
3 936 807 $
9 384 319 $
4 858 298 $
3 338 907 $
3 250 457 $
-1 372 415 $
1 220 164 $
3 111 287 $
6 302 988 $
8 626 750 $
16 324 153 $
19 978 971 $
13 042 154 $
22 851 964 $
22 396 007 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-4 910 449 $
-4 772 509 $
228 944 $
-4 567 329 $
-5 331 192 $
-8 283 776 $
-
-
-9 214 186 $
-4 698 715 $
-9 168 465 $
Last revenue report of Akari Therapeutics, Plc was 31/03/2021. According to last financial report total revenue in Akari Therapeutics, Plc was 0 US dollar and changed by 0% since last year. Net income in Akari Therapeutics, Plc was -5 838 501 $ in last quartal, net income changes to 0%.
